Lucid Diagnostics Inc.: net inventory
Net inventory for Lucid Diagnostics Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Lucid Diagnostics Inc. financial histories
What this measure means
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
Exact concept: us-gaap:InventoryNet. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2022-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 353,000 | USD | 2026-03-25 | 10-K · 0001437749-26-009805 |
| At date | 2024-12-31 | 341,000 | USD | 2026-03-25 | 10-K · 0001437749-26-009805 |
| At date | 2023-12-31 | 278,000 | USD | 2025-03-24 | 10-K · 0001641172-25-000205 |
| At date | 2022-12-31 | 111,000 | USD | 2024-03-25 | 10-K · 0001493152-24-011161 |
Related financial histories
- Lucid Diagnostics Inc.: total assets
- Lucid Diagnostics Inc.: total liabilities
- Lucid Diagnostics Inc.: stockholders equity
- Lucid Diagnostics Inc.: cash and cash equivalents
- Lucid Diagnostics Inc.: net income or loss
- Lucid Diagnostics Inc.: operating cash flow
- Lucid Diagnostics Inc.: capital expenditure payments
- Lucid Diagnostics Inc.: revenue
- Lucid Diagnostics Inc.: contract revenue excluding tax
- Lucid Diagnostics Inc.: financing cash flow
- Lucid Diagnostics Inc.: investing cash flow
- Lucid Diagnostics Inc.: retained earnings or deficit
- Lucid Diagnostics Inc.: basic weighted-average shares
- Lucid Diagnostics Inc.: diluted weighted-average shares
- Lucid Diagnostics Inc.: basic earnings per share
- Lucid Diagnostics Inc.: diluted earnings per share
- Lucid Diagnostics Inc.: net property, plant and equipment
- Lucid Diagnostics Inc.: share-based compensation expense
- Lucid Diagnostics Inc.: operating income or loss
- Lucid Diagnostics Inc.: current assets
- Lucid Diagnostics Inc.: interest expense
- Lucid Diagnostics Inc.: current liabilities
- Lucid Diagnostics Inc.: current accounts payable
- Lucid Diagnostics Inc.: net finite-lived intangible assets
- Lucid Diagnostics Inc.: net current accounts receivable
- Lucid Diagnostics Inc.: operating expenses
- Lucid Diagnostics Inc.: cost of revenue
- Lucid Diagnostics Inc.: research and development expense
Inspect the source
- Entity
- Lucid Diagnostics Inc. / CIK 0001799011
- Captured
- 2026-09-21T17:32:25.713Z
- SEC response SHA-256
affd343510d62edd69fc49ce28bdc9da5b7ae8b6099e46b58ad0cf5326ad10d8
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001799011.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))